Section 26B-4-231 - Partial filling - Pharmacy medical provider directions of use(1) As used in this section, "partially fill" means to provide less than the full amount of cannabis or cannabis product that the recommending medical provider recommends, if the recommending medical provider recommended specific dosing guidelines.(2) A pharmacy medical provider may partially fill a recommendation for a medical cannabis treatment at the request of the recommending medical provider who issued the medical cannabis treatment recommendation or the medical cannabis cardholder.(3) The department shall make rules, in collaboration with the Division of Professional Licensing and the Board of Pharmacy and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, specifying how to record the date, quantity supplied, and quantity remaining of a partially filled medical cannabis treatment recommendation.(4) A pharmacy medical provider who is a pharmacist may, upon the request of a medical cannabis cardholder, determine different dosing guidelines, subject to the dosing limits in Subsection 4-41a-1102(2), to fill the quantity remaining of a partially filled medical cannabis treatment recommendation if:(a) the pharmacy medical provider determined dosing guidelines for the partial fill under Subsection 4-41a-1102(5) or (6); and(b) the medical cannabis cardholder reports that: (i) the partial fill did not substantially affect the qualifying condition underlying the medical cannabis recommendation; or(ii) the patient experienced an adverse reaction to the partial fill or was otherwise unable to successfully use the partial fill.(5) If a recommending medical provider recommends treatment with medical cannabis but wishes for the pharmacy medical provider to determine directions of use and dosing guidelines:(a) the recommending medical provider shall provide to the pharmacy medical provider, either through the state electronic verification system or through a medical cannabis pharmacy's recording of a recommendation under the order of a limited medical provider, any of the following information that the recommending medical provider feels would be needed to provide appropriate directions of use and dosing guidelines:(i) information regarding the qualifying condition underlying the recommendation;(ii) information regarding prior treatment attempts with medical cannabis; and(iii) portions of the patient's current medication list; and(b) before the relevant medical cannabis cardholder may obtain medical cannabis, the pharmacy medical provider shall: (i) review pertinent medical records, including the recommending medical provider documentation described in Subsection (5)(a); and(ii) after completing the review described in Subsection (5)(b)(i) and consulting with the recommending medical provider as needed, determine the best course of treatment through consultation with the cardholder regarding: (A) the patient's qualifying condition underlying the recommendation from the recommending medical provider;(B) indications for available treatments;(C) directions of use and dosing guidelines; and(D) potential adverse reactions.Amended by Chapter TBD, 2024 General Session ,§ 9, eff. 5/1/2024.Renumbered from § 26-61a-503 and amended by Chapter 273, 2023 General Session ,§ 39, eff. 7/1/2023.Amended by Chapter 317, 2023 General Session ,§ 19, eff. 5/3/2023.Amended by Chapter 415, 2022 General Session ,§ 28, eff. 5/4/2022.Amended by Chapter 337, 2021 General Session ,§ 13, eff. 3/17/2021.Amended by Chapter 5, 2019SP1 General Session ,§ 37, eff. 9/23/2019.Added by Chapter 1, 2018SP3 General Session ,§ 74, eff. 12/3/2018.